Finn MacLean
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Finn MacLean has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Adino Tesfahun Tsegaye
Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, MD
2 shared publications - Ayumi Saito
Department of Global Health, University of Washington, Seattle, Washington, USA
2 shared publications - Bhavna H. Chohan
Department of Global Health, University of Washington, Seattle, Washington, USA
2 shared publications Irene Cruz Talavera
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
2 shared publications- Jairam R. Lingappa
Department of Global Health, University of Washington, Seattle, Washington, USA
2 shared publications - Jennifer M. Lund
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
2 shared publications
Latest Publications
- Open Access
- 18 November 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (1)
Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cells
Herpes Simplex Virus 2 (HSV-2) infection results in variable rates of local viral shedding in anogenital skin. The effect of episodic viral exposures on immune cells in adjacent mucosal tissues, including the genital tract, is unknown. However, any immune responses at this site could affect protective mucosal immunity, tissue homeostasis, and adverse health outcomes. To investigate the effect of HSV-2 on cervicovaginal tract immunity, we applied flow cytometry, immunofluorescence imaging, analysis of soluble immune factors, and spatial transcriptomics to cervicovaginal tissue and blood samples provided by a total of 232 HSV-2–seropositive and seronegative participants, with genital HSV-2 shedding evaluated at the time of biopsy. This unique dataset was used to define and spatially map immune cell subsets and localized gene expression via spatial transcriptomics. HSV-2 seropositivity alone was associated with minimal differences in cervicovaginal and circulating T cell phenotypes. However, the vaginal mucosa during active HSV-2 shedding was associated with alterations in T cell, macrophage, and DC localization and gene expression, consistent with increased immune surveillance, with immune activating and suppressing signals potentially reinforcing mucosal tissue homeostasis.
- 18 November 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (1)
Open AccessGenital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cells
Herpes Simplex Virus 2 (HSV-2) infection results in variable rates of local viral shedding in anogenital skin. The effect of episodic viral exposures on immune cells in adjacent mucosal tissues, including the genital tract, is unknown. However, any immune responses at this site could affect protective mucosal immunity, tissue homeostasis, and adverse health outcomes. To investigate the effect of HSV-2 on cervicovaginal tract immunity, we applied flow cytometry, immunofluorescence imaging, analysis of soluble immune factors, and spatial transcriptomics to cervicovaginal tissue and blood samples provided by a total of 232 HSV-2–seropositive and seronegative participants, with genital HSV-2 shedding evaluated at the time of biopsy. This unique dataset was used to define and spatially map immune cell subsets and localized gene expression via spatial transcriptomics. HSV-2 seropositivity alone was associated with minimal differences in cervicovaginal and circulating T cell phenotypes. However, the vaginal mucosa during active HSV-2 shedding was associated with alterations in T cell, macrophage, and DC localization and gene expression, consistent with increased immune surveillance, with immune activating and suppressing signals potentially reinforcing mucosal tissue homeostasis.
- Open Access
- 25 March 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (10)
Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract
BACKGROUND: Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that is prevalent among reproductive-age females worldwide. Adverse health outcomes associated with BV include an increased risk of sexually acquired HIV, yet the immunological mechanisms underlying this association are not well understood. METHODS: To investigate BV-driven changes to cervicovaginal tract (CVT) and circulating T cell phenotypes, Kinga Study participants with or without BV provided vaginal tract (VT) and ectocervical (CX) tissue biopsies and PBMC samples. RESULTS: High-parameter flow cytometry revealed an increased frequency of cervical CD4 + conventional T (Tconv) cells expressing CCR5 in BV + versus BV – women. However, we found no difference in the number of CD3 + CD4 + CCR5 + cells in the CX or VT of BV + versus BV – individuals, suggesting that BV-driven increased HIV susceptibility may not be solely attributed to increased CVT HIV target cell abundance. Flow cytometry also revealed that individuals with BV had an increased frequency of dysfunctional CX and VT CD39 + Tconv and CX tissue-resident CD69 + CD103 + Tconv cells, reported to be implicated in HIV acquisition risk and replication. Many soluble immune factor differences in the CVT further support that BV elicits diverse and complex CVT immune alterations. CONCLUSION: Our comprehensive analysis expands on potential immunological mechanisms that may underlie the adverse health outcomes associated with BV, including increased HIV susceptibility. TRIAL REGISTRATION: ClinicalTrials.gov NCT03701802. FUNDING: This work was supported by National Institutes of Health grants R01AI131914, R01AI141435, and R01AI129715.
- 25 March 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (10)
Open AccessBacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract
BACKGROUND: Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that is prevalent among reproductive-age females worldwide. Adverse health outcomes associated with BV include an increased risk of sexually acquired HIV, yet the immunological mechanisms underlying this association are not well understood. METHODS: To investigate BV-driven changes to cervicovaginal tract (CVT) and circulating T cell phenotypes, Kinga Study participants with or without BV provided vaginal tract (VT) and ectocervical (CX) tissue biopsies and PBMC samples. RESULTS: High-parameter flow cytometry revealed an increased frequency of cervical CD4 + conventional T (Tconv) cells expressing CCR5 in BV + versus BV – women. However, we found no difference in the number of CD3 + CD4 + CCR5 + cells in the CX or VT of BV + versus BV – individuals, suggesting that BV-driven increased HIV susceptibility may not be solely attributed to increased CVT HIV target cell abundance. Flow cytometry also revealed that individuals with BV had an increased frequency of dysfunctional CX and VT CD39 + Tconv and CX tissue-resident CD69 + CD103 + Tconv cells, reported to be implicated in HIV acquisition risk and replication. Many soluble immune factor differences in the CVT further support that BV elicits diverse and complex CVT immune alterations. CONCLUSION: Our comprehensive analysis expands on potential immunological mechanisms that may underlie the adverse health outcomes associated with BV, including increased HIV susceptibility. TRIAL REGISTRATION: ClinicalTrials.gov NCT03701802. FUNDING: This work was supported by National Institutes of Health grants R01AI131914, R01AI141435, and R01AI129715.